Future research should investigate the potential of agents with anti‐inflammatory or endothelial‐protective properties—such as statins, ACE inhibitors or novel immunomodulatory drugs—as adjunct treatments in methamphetamine dependence. The gene discussed is ACE; the disease is methamphetamine dependence.